NISSHA Acquires Vietnamese Medical Device Manufacturer USM HEALTHCARE as Subsidiary – M&A Online

NISSHA's Acquisition of Vietnamese USM HEALTHCARE as a Subsidiaryis not merely a piece of news about global expansion, but suggests the importance of M&A in the business strategy of domestic medical device manufacturers. In particular,the utilization of M&A as a growth strategy in the medical device sectoris a trend that domestic medical institution managers should also pay attention to.

In the context of medical M&A and business succession, this is considered to have a strong aspect of"M&A for business scale expansion and entry into new markets."In anticipation of market maturation and intensifying competition domestically, moves to seek growth opportunities through overseas expansion will likely accelerate in the future. This suggests that domestic medical institutions should consider M&A not just for resolving succession issues, but for"sustainable business growth and the creation of new value."This can also be interpreted as a message that...

For medical institution managers facing succession issues and readers considering business succession, the implication is that it is important to have a perspective on"how their own institution's business is evaluated externally and what kind of growth strategies it could be incorporated into."The case of acquiring companies with strengths in specific regions or products, like USM HEALTHCARE, by companies with greater capital, aiming for further growth, is applicable to domestic medical institutions as well. It is crucial to objectively analyze one's own institution's strengths and future potential, and to recognize the value of consulting with experts from an early stage, viewing third-party succession M&A not merely as a means of "business termination," but as"a transition to a new stage of business."It is important to recognize the value of consulting with experts from an early stage.